Drug Profile
Research programme: Antiviral therapeutics - Ildong Pharmaceuticals
Alternative Names: IDR-7042Latest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator Ildong Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Viral infections in South Korea (unspecified route)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Viral-infections in South Korea
- 19 Oct 2015 Ildong Pharmaceuticals has patent protection for IDR 7042 in USA, European Union and Japan